Britannia Life Sciences Income Statement

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	0.26	0.37	0.52	6.4	7.3	1.42
Revenue Growth (YoY)	-	-28.55%	-91.93%	-12.28%	412.42%	-
Cost of Revenue	0.42	0.34	0.38	1.77	2.04	0.25
Gross Profit	-0.16	0.03	0.14	4.64	5.26	1.18
Selling, General & Admin	2.57	2.24	1.46	2.59	2.54	0.79
Other Operating Expenses	-	-	-	-	-	0.1
Operating Expenses	2.58	2.24	1.69	3.64	3.65	0.89
Operating Income	-2.74	-2.22	-1.55	0.99	1.62	0.29
Interest Expense	-0.1	-0.11	-0.1	-0.85	-2.31	-0.36
Earnings From Equity Investments	-3.17	-2.09	-0.96	-0.02	-0	-
Currency Exchange Gain (Loss)	0.61	-0.4	-0.11	-0.06	0.61	0.19
Other Non Operating Income (Expenses)	0.12	0.06	-3.82	4.41	-3.22	0.29
EBT Excluding Unusual Items	-5.18	-4.75	-6.54	4.47	-3.3	0.41
Impairment of Goodwill	-	-	-0.04	-	-	-
Gain (Loss) on Sale of Assets	1.78	0.23	0.47	1.39	-	-
Other Unusual Items	0.08	-0.04	-	-	-9.97	-0.01
Pretax Income	-3.32	-4.56	-6.12	5.86	-13.27	0.4
Income Tax Expense	-	-	-	0.02	0.71	0.26
Earnings From Continuing Operations	-3.32	-4.56	-6.12	5.84	-13.99	0.14
Earnings From Discontinued Operations	11.48	12.07	1.72	-	-	-
Net Income to Company	8.16	7.51	-4.4	5.84	-13.99	0.14
Minority Interest in Earnings	0.07	-0.11	-0.37	-0.75	-1.47	-0.3
Net Income	8.22	7.39	-4.77	5.08	-15.46	-0.16
Net Income to Common	8.22	7.39	-4.77	5.08	-15.46	-0.16
Shares Outstanding (Basic)	162	162	162	162	110	78
Shares Outstanding (Diluted)	162	162	162	162	110	78
Shares Change (YoY)	-0.03%	-	0.07%	48.07%	41.06%	1138.06%
EPS (Basic)	0.05	0.05	-0.03	0.03	-0.14	-0.00
EPS (Diluted)	0.05	0.05	-0.03	0.03	-0.14	-0.00
Free Cash Flow	-4.4	-2.62	2.09	1.95	2.71	-0.54
Free Cash Flow Per Share	-0.03	-0.02	0.01	0.01	0.03	-0.01
Gross Margin	-61.77%	7.40%	26.65%	72.43%	72.08%	82.64%
Operating Margin	-1050.23%	-599.98%	-299.60%	15.52%	22.13%	20.23%
Profit Margin	3155.76%	2001.95%	-922.51%	79.39%	-211.76%	-11.03%
Free Cash Flow Margin	-1687.88%	-709.38%	404.71%	30.50%	37.16%	-38.15%
EBITDA	-2.63	-2.11	-1.42	1.1	1.75	0.32
EBITDA Margin	-	-	-275.67%	17.25%	24.02%	22.24%
D&A For EBITDA	0.1	0.1	0.12	0.11	0.14	0.03
EBIT	-2.74	-2.22	-1.55	0.99	1.62	0.29
EBIT Margin	-	-	-299.60%	15.52%	22.13%	20.23%
Effective Tax Rate	-	-	-	0.34%	-	64.31%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.